Results 71 to 80 of about 23,012 (218)

Protective effect of vaccination against mumps complications, Czech Republic, 2007–2012

BMC Public Health, 2016
Background In the Czech Republic, two-dose immunization against mumps achieves 98 % coverage. The routine reporting detects mumps cases, clinical complications, and hospital admissions in unvaccinated but also in vaccinated individuals.
Hana Orlíková, Marek Malý, Pavla Lexová, Helena Šebestová, Radomíra Limberková, Lucie Jurzykowská, Jan Kynčl   +6 more
doaj   +1 more source

Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age [PDF]

, 2018
H. Haas, Patrick O. Richard, Cécile Eymin, Anne Fiquet, Barbara J. Kuter, B. Soubeyrand   +5 more
openalex   +1 more source

Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program

Journal of Infection in Developing Countries, 2016
Introduction: mumps vaccination implementation in the form of MMR – measles, mumps, and rubella) in Thailand for first-grade school students since 1997 and for infants 9–12 months of age since 2010 resulted in a dramatic decline in the incidence of and ...
Varisara Ngaovithunvong, Nasamon Wanlapakorn, Lita Tesapirat, Narrissara Suratannon, Yong Poovorawan   +4 more
doaj   +1 more source

Evaluation of efficacy and safety of intralesional vitamin D3 in comparison with intralesional measles, mumps and rubella (MMR) vaccine in the treatment of multiple cutaneous warts

, 2023
Vijay Deepak Joshi, Shekhar N Pradhan, VVasudha Abhijit Belgaumkar   +2 more
openalex   +1 more source

THE RESULTS OF STUDY OF THE LEVELS OF SPECIFIC ANTIBODIES TO THE COMBINED INJECTION VACCINES AGAINST INFLUENZA, MEASLES, RUBELLA AND MUMPS AND DT IN CHILDREN WITH CHRONIC PHYSICAL ILLNESS

Детские инфекции (Москва), 2015
The levels of antibodies to the separate and combined administration of the vaccine plus Grippol® Plus and vaccines against measles, mumps and/or rubella, diphtheria and tetanus (DT) in children with chronic medical illnesses, including HIV and organic ...
S. M. Haritе, A. A. Ruleva, O. V. Goleva, O. S. Kalinogorskaya, V. A. Apryatina   +4 more
doaj   +1 more source

Development of Improved Mumps Vaccine Candidates by Mutating Viral mRNA Cap Methyltransferase Sites in the Large Polymerase Protein. [PDF]

Virol Sin, 2021
Hao X, Wang Y, Zhu M, Zhou D, Liu R, Wang B, Huang YW, Zhao Z.   +7 more
europepmc   +1 more source

A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults [PDF]

, 2019
Patricia Kaaijk, Alienke J. Wijmenga‐Monsuur, Marlies A. van Houten, Irene Veldhuijzen, Hinke I ten Hulscher, Jeroen Kerkhof, Fiona van der Klis, Rob van Binnendijk   +7 more
openalex   +1 more source

Measles, Mumps, and Rubella Antibody: Patterns of Persistence and Rate of Decline Following the Second Dose of the MMR Vaccine [PDF]

, 2017
Emma E. Seagle, Robert A. Bednarczyk, Tenisha Hill, Amy Parker Fiebelkorn, Carole J. Hickman, Joseph P. Icenogle, Edward A. Belongia, Huong Q. McLean   +7 more
openalex   +1 more source

Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, Canada [PDF]

, 2020
Wallis Rudnick, Sarah E. Wilson, Jo Ann Majerovich, Michelle Haavaldsrud, Marene Gatali, Cai-Lei Matsumoto, Shelley L. Deeks   +6 more
openalex   +1 more source

Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine. [PDF]

, 1992
Caroline Benjamin, Grace Chew, Alan J. Silman   +2 more
openalex   +1 more source